Sponsored by:

Nuclear Medicine: Page 56

Jubilant forms new radiopharmaceutical company
By AuntMinnie.com staff writers
Jubilant Pharma has launched Jubilant Radiopharma, a new company that will bring its Jubilant DraxImage Radiopharmacies and Jubilant DraxImage radiopharmaceutical development businesses together under the umbrella of a single radiopharmaceutical brand.
June 18, 2019
Sofie Biosciences acquires Texas radiopharmacy
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has acquired Houston Cyclotron Partners, a cyclotron radiopharmacy based in Houston.
June 16, 2019
Blue Earth highlights SNMMI 2019 presentations
By AuntMinnie.com staff writers
Molecular imaging firm Blue Earth Diagnostics is touting 16 presentations involving its Axumin PET radiopharmaceutical and "radiohybrid" prostate-specific membrane antigen imaging agent at next week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 13, 2019
Navidea readies public stock offering
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is planning to raise $6 million in a new public offering of its common stock.
June 13, 2019
ANSTO licensed to fully supply Mo-99
By AuntMinnie.com staff writers
The Australian Nuclear Science and Technology Organisation (ANSTO) has received a license to begin full production of molybdenum-99 (Mo-99) at its new nuclear facility.
June 11, 2019
2019 06 12 21 55 5218 Atom Earth 400
Israeli firm creates unique Mo-99 production process
By AuntMinnie.com staff writers
Researchers at BGN Technologies have developed a method designed to simultaneously produce molybdenum-99 (Mo-99) and other medical isotopes without highly enriched uranium.
June 6, 2019
ANSTO nets funds for nuclear medicine project
By AuntMinnie.com staff writers
The state government of New South Wales in Australia will invest 12.5 million Australian dollars ($8.74 million U.S.) in an initiative to expand and advance nuclear medicine capabilities at the Australian Nuclear Science and Technology Organisation (ANSTO), a major source of radioisotopes.
June 3, 2019
NRC offers options for radiopharmaceutical training
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) has proposed four options relative to current requirements to administer radiopharmaceuticals, including reducing the number of training and experience hours from 700 to 400.
June 3, 2019
2018 12 11 00 02 7009 Atom Nuclear Lab 400
NaF-PET/CT rarely finds prostate cancer bone metastases
By Wayne Forrest
Sodium fluoride (NaF) PET/CT rarely adds value for detecting bone metastases in patients with intermediate- and high-risk prostate cancer and normal bone scintigraphy results prior to prostatectomy, according to a study published online May 30 in the Journal of Nuclear Medicine.
June 2, 2019
2019 04 17 20 48 2514 Prostate 3 D 400
Lantheus inks radiopharma deal with NanoMab
By AuntMinnie.com staff writers
Lantheus Holdings, the parent company of Lantheus Medical Imaging, has entered into a strategic collaboration and license agreement with biopharmaceutical firm NanoMab Technology to develop next-generation radiopharmaceuticals for immuno-oncology therapies.
May 30, 2019
Deep learning advances SPECT MPI
By AuntMinnie.com staff writers
Using deep learning to analyze upright and supine SPECT myocardial perfusion images (MPI) could improve the diagnosis of obstructive coronary artery disease, according to a multicenter international study published in the May issue of the Journal of Nuclear Medicine.
May 28, 2019
Eden nets funding for Mo-99 reactor
By AuntMinnie.com staff writers
Eden Radioisotopes has signed an investment agreement with oil and gas company Abo Empire to build a medical isotope production reactor in New Mexico. The planned reactor of less than 2 megawatts of power will primarily manufacture molybdenum-99 (Mo-99), the precursor to technetium-99m.
May 21, 2019
Previous Page
Page 56 of 438
Next Page